We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Phenothiazine Effects in Good Premorbid Schizophrenics Divided Into Paranoid-Nonparanoid Status

Lewis L. Judd, MD; Michael J. Goldstein, PhD; Eliot H. Rodnick, PhD; Newton L.P. Jackson Jr., PhD
Arch Gen Psychiatry. 1973;29(2):207-211. doi:10.1001/archpsyc.1973.04200020045005.
Text Size: A A A
Published online


Twenty-four good premorbid schizophrenics, divided on the basis of paranoid-nonparanoid status, were studied under a double-blind design for differential responses to a phenothiazine medication while receiving drug and placebo regimens.

Autonomic responsivity levels measured by skin resistance and related to drug status did not distinguish between the paranoid-nonparanoid status patients. Significant findings emerged in the interactions between paranoid-nonparanoid status and the drug-placebo condition on only the cognitive and perceptual measures.

The paranoid patient on placebo status consistently did very poorly in both the clinical ratings and the experimental tasks. The nonparanoid patients showed only mild-to-moderate improvement effects while receiving medication and the performance of the nonparanoid receiving placebo was often very similar to that of the paranoid given drugs.

The findings of this study and others emphasize the importance of using the paranoid-nonparanoid and good-poor premorbid groupings when doing clinical and experimental research on schizophrenics.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.